APA aipamena

Zhu, J. f., Li, Z. j., Zhang, G. s., Meng, K., Kuang, W. y., Li, J., . . . Liu, S. f. (2011). Icaritin Shows Potent Anti-Leukemia Activity on Chronic Myeloid Leukemia In Vitro and In Vivo by Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings. Public Library of Science.

Chicago Style aipamena

Zhu, Jian feng, et al. Icaritin Shows Potent Anti-Leukemia Activity On Chronic Myeloid Leukemia In Vitro and In Vivo By Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings. Public Library of Science, 2011.

MLA aipamena

Zhu, Jian feng, et al. Icaritin Shows Potent Anti-Leukemia Activity On Chronic Myeloid Leukemia In Vitro and In Vivo By Regulating MAPK/ERK/JNK and JAK2/STAT3 /AKT Signalings. Public Library of Science, 2011.

Kontuz: berrikusi erreferentzia hauek erabili aurretik.